Small Molecules
6 April 2013
Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases4 April 2013
Aragon Announces First Patient Dosed in Phase I Study of ARN-810 in Estrogen Receptor Positive Breast Cancer4 April 2013
Beech Tree Labs Announces Successful Completion of IND Phase 1/2a Oral Herpes Clinical Trial1 April 2013
Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-21271071 April 2013
U.S. FDA Approves INVOKANA™ (Canagliflozin) for the Treatment of Adults with Type 2 Diabetes1 April 2013
ArQule Regains Worldwide Rights to AKT Program1 April 2013
pSivida Reports on Resubmission to FDA of NDA for ILUVIEN for Chronic Diabetic Macular Edema28 March 2013
Biogen Idec’s TECFIDERA (Dimethyl Fumarate) Approved in US as a First-Line Oral Treatment for Multiple Sclerosis27 March 2013
Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids26 March 2013
Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia26 March 2013
Trius Announces Positive Results From ESTABLISH 2 Study of Tedizolid in Severe Skin Infections26 March 2013
BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4161 for the Treatment of Hereditary AngioedemaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports